It is reported that ochratoxin A (OTA) impairs urinary acidification by increasing the urinary pH and also increases the intracellular pH in Madin-Darby canine kidney cells. This study was designed to examine whether OTA deranges pH homeostasis in the interstitium (or vasa recta) of the renal papilla. Rats were injected once with OTA (3 μmol/kg body weight) intravenously (acute application) or with OTA (1.25 μmol/kg body weight/day) intraperitoneally for 6 days (subchronic application). We measured the pH values in both the descending and ascending vasa recta blood (VR) in the renal papilla. Both the acute and subchronic applications of OTA led to significant increases in pH values in both descending and ascending VR by 0.4f 0.6 pH units. However, no significant increases in pH values in renal arterial and aortic blood in OTA-treated rats were observed. We also examined the pH changes in collecting-duct urine after OTA injection (3 μmol/kg body weight). We found a significant increase in pH values 30 min after OTA injection; this significant elevation of pH values was present during the whole experiment (120 min). The results of this study suggest that OTA deranges pH homeostasis in the interstitium of the renal papilla, in addition to the impairment of urinary acidification.

Keywords:
Ochratoxin A, Nephrotoxicity, pH homeostasis, pH microelectrode, Vasa recta, Renal papilla
This content is only available via PDF.
© 1997 S. Karger AG, Basel
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.